Jeff Yass’s Opus Genetics IRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$60K Buy
+12,400
New +$51.5K ﹤0.01% 12814
2022
Q2
– Sell
-22,600
Closed -$73K – 14136
2022
Q1
$73K Buy
22,600
+11,200
+98% +$38.3K ﹤0.01% 12109
2021
Q4
$43K Sell
11,400
-56,000
-83% -$225K ﹤0.01% 12623
2021
Q3
$347K Buy
+67,400
New +$311K ﹤0.01% 10267

Other funds holding IRD

Jeff Yass's IRD Position: Q3 2026 in Review

Jeff Yass increased its Opus Genetics (IRD) stake by 78% in Q3 2026, buying an estimated $636K and bringing the position to 350,141 shares worth $1.69M. The position accounts for ﹤0.01% of the portfolio, ranked #6669.

Jeff Yass first reported a position in IRD in Q4 2014 and has held it in 25 quarters since. The position peaked at $3.75M in Q1 2026. 112 funds tracked by Wall St. Rank hold IRD as of Q3 2026.

  • Jeff Yass held 350,141 shares of Opus Genetics worth $1.69M as of Q3 2026.
  • Jeff Yass bought 153,244 Opus Genetics shares in Q3 2026, an estimated $636K.
  • Opus Genetics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #6669 holding.
  • Jeff Yass first reported a position in Opus Genetics in Q4 2014 and has held it in 25 quarters since.
  • Jeff Yass's Opus Genetics position peaked at $3.75M in Q1 2026.
  • 112 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.